| Douglas S Bell, MD | |
|
333 N Green Bay Rd, Neenah, WI 54956-1954 | |
| (920) 720-2300 | |
| (920) 720-3719 |
| Full Name | Douglas S Bell |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 333 N Green Bay Rd, Neenah, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548750284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301114895 (Michigan) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 81069 (Wisconsin) | Primary |
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
Every year at least 30 million women in malaria-endemic areas of Africa become pregnant. Many of them develop placental malaria, a pregnancy-specific form of the disease, which frequently results in low birth weight of the child.
Postprocedural asymmetry following percutaneous coronary intervention is associated with an increased risk of adverse clinical outcome, particularly in patients with suboptimal expansion, researchers report.
NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.
Ecolab Inc. today announced the launch of Virasept, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores.
› Verified 4 days ago
| Entity Name | Milwaukee Behavioral Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497324115 PECOS PAC ID: 4789089954 Enrollment ID: O20220112000844 |
News Archive
Every year at least 30 million women in malaria-endemic areas of Africa become pregnant. Many of them develop placental malaria, a pregnancy-specific form of the disease, which frequently results in low birth weight of the child.
Postprocedural asymmetry following percutaneous coronary intervention is associated with an increased risk of adverse clinical outcome, particularly in patients with suboptimal expansion, researchers report.
NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.
Ecolab Inc. today announced the launch of Virasept, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas S Bell, MD 333 N Green Bay Rd, Neenah, WI 54956-1954 Ph: (920) 720-2300 | Douglas S Bell, MD 333 N Green Bay Rd, Neenah, WI 54956-1954 Ph: (920) 720-2300 |
News Archive
Every year at least 30 million women in malaria-endemic areas of Africa become pregnant. Many of them develop placental malaria, a pregnancy-specific form of the disease, which frequently results in low birth weight of the child.
Postprocedural asymmetry following percutaneous coronary intervention is associated with an increased risk of adverse clinical outcome, particularly in patients with suboptimal expansion, researchers report.
NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.
Ecolab Inc. today announced the launch of Virasept, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores.
› Verified 4 days ago
Daniel Long, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1305 W American Dr, Neenah, WI 54956 Phone: 800-201-1194 Fax: 920-725-7392 | |
Kelley Jane Parnell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1305 W American Dr, Neenah, WI 54956 Phone: 800-201-1194 Fax: 920-720-7392 | |
Dr. Kimberly Sue Hoenecke, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-3100 | |
Joseph J Jares Iii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 318 Park Dr, Neenah, WI 54956 Phone: 360-539-8487 Fax: 360-358-9944 | |
Mr. Stephen L Shopbell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1136 Westowne Dr, Neenah, WI 54956 Phone: 920-456-2030 | |
Mr. Thomas Gerard Mattio, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1305 W American Dr, Neenah, WI 54956 Phone: 920-725-9373 Fax: 920-720-7392 | |
Mr. Steven James Price, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1305 W American Dr, Neenah, WI 54956 Phone: 920-725-9373 Fax: 920-720-7392 |